Alzheimer’s drug results leave Lilly ‘excited’ but uncertain
The surprise positive effect shown by an experimental Alzheimer’s drug “excited” executives at Eli Lilly and Co., but it raised as many questions as it answered.
Health Care
Articles
Lilly’s Alzheimer’s drug trials show mixed results
Eli Lilly and Co.’s experimental Alzheimer’s drug failed to meet its primary goals in two separate clinical trials. However, when the results of both trials were combined, the drug appeared to have slowed the decline of cognition in some patients.
Big WellPoint investor Royal Capital calls for CEO’s ouster
Royal Capital Management LLC is calling for the ouster of WellPoint Inc. CEO Angela Braly in a letter to the health insurer, saying she has “failed miserably.”
Cutting bills fuels growth of Health Systems International
Health Systems is on pace this year for nearly $50 million in revenue, up from $42 million last year and just $4.5 million eight years ago. The Indianapolis company processes claims for health insurers when patients receive out-of-network care.
FDA names Indiana farm tied to salmonella in melons
The Food and Drug Administration has identified a southern Indiana farm that produced cantaloupes linked to a deadly salmonella outbreak and says the operation has recalled its melons.
Pence asks Daniels to deny state-run exchange
Republican gubernatorial candidate Mike Pence is asking Gov. Mitch Daniels to reject a state-run health insurance exchange called for by the federal health care law.
Humane Society clinic to open with even bigger goal in mind
The Humane Society of Indianapolis is ready to open its new Animal Welfare Center in Haughville, featuring a low-cost vaccination clinic. The group wants to raise $750,000 to add a low-cost spay-and-neuter clinic to the center.
WellPoint competitor Aetna to buy Coventry for $5.6B
Aetna joins rivals WellPoint Inc. and Cigna Corp. in making big acquisitions as the U.S. government expands medical coverage.
Alzheimer’s quest puts Lilly to test
Odds are long that Eli Lilly and Co.’s leading Alzheimer’s drug will show positive results when its Phase 3 trial results are released within a few weeks, but even the smallest improvement in the cognitive impairment of test patients would be a home run for Lilly.
Lilly to book $790M Amylin payment in third quarter
Eli Lilly and Co. will book about $790 million in pretax income in the third quarter thanks to an early payment from former drug development partner Amylin Pharmaceuticals.
Brater to retire as dean of IU medical school
Dr. Craig Brater, 66, has worked at the Indianapolis-based school for 26 years, including the past 12 as dean. The school is the second largest medical school in the nation and the only one in Indiana.
Lilly stock slips after competitors halt Alzheimer’s plans
Pfizer Inc., Johnson & Johnson and Elan Corp. are ending most plans to develop an Alzheimer’s drug after a second trial failure. Eli Lilly is developing a similar treatment.
Governors aside, feds building health care exchanges
The feds may be gaining on GOP governors who've balked at carrying out a key part of the health care overhaul law. Opponents of the law say they won't set up new private health insurance exchanges. But increasingly it's looking like Washington will do it for them.
Despite funding dip, IU bets on brains
The city that brought the world Prozac and other neuroscience drugs is doubling down on brain research with a new $52 million research center near Methodist Hospital.
Cautious hospitals trouble Hill-Rom
The investor drubbing sustained by Hill-Rom Holdings Inc. last week stemmed not so much from the new acquisition it announced as from the gloomy outlook in the North American hospital market.
Lilly braces for decline in Europe
Austerity and upheaval in Europe have not hurt Eli Lilly and Co.’s $4 billion-a-year drug business there, but the company is moving forward with plans to survive a coming swoon anyway.
Health insurers’ anti-fraud bid seeks to ease profit-limit rule
The Obama administration Thursday announced a partnership with the industry in which WellPoint Inc., UnitedHealth Group Inc. and other insurers may try to share more billing data with the government to root out fraud.
Multi-employer health clinic to open downtown
NoviaCare Clinics LLC will open a multi-employer health clinic in downtown Indianapolis this fall, opening the door for smaller employers to add the service to their health benefits.
Cook Medical shelves Midwest expansion plans
Cook Medical Inc. had been planning to open five new manufacturing plants over the next five years in small communities around the Midwest, including Indiana, but has shelved those plans because of the hit it will take from a new U.S. tax on medical devices.
Hill-Rom stock swoons after $400M acquisition
Investors reacted negatively Thursday after medical equipment and hospital bed maker Hill-Rom Holdings Inc. on Wednesday said it was acquiring Aspen Surgical Products for $400 million.